
Ampio Pharmaceuticals AMPE
Geschäftsbericht 2023
hinzugefügt 27.03.2024
Ampio Pharmaceuticals EV/EBITDA 2011-2025 | AMPE
EV/EBITDA Jährlich Ampio Pharmaceuticals
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -20.4 | -18.1 | -4.44 | -2.94 | -12.7 | -2.91 | -3.16 | -5.22 | -13 | -9.62 | -8.54 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -2.91 | -20.4 | -9.19 |
EV/EBITDA anderer Aktien in der Pharmaeinzelhändler
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
ARCA biopharma
ABIO
|
1.84 | - | 1052.0 % | $ 415 M | ||
|
AbbVie
ABBV
|
11.9 | $ 223.01 | -0.99 % | $ 395 B | ||
|
Alpine Immune Sciences
ALPN
|
-5.5 | - | - | $ 2.17 B | ||
|
Arbutus Biopharma Corporation
ABUS
|
-3.41 | $ 4.68 | 1.85 % | $ 777 M | ||
|
Aclaris Therapeutics
ACRS
|
-9.24 | $ 3.38 | 3.21 % | $ 261 M | ||
|
AlloVir
ALVR
|
-3.61 | - | 4.14 % | $ 49.1 M | ||
|
Acasti Pharma
ACST
|
1.8 | - | 4.01 % | $ 150 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
-12.7 | - | -15.15 % | $ 60.3 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-4.27 | - | - | $ 1.01 B | ||
|
Ascendis Pharma A/S
ASND
|
-15.7 | $ 212.3 | 5.5 % | $ 5 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
10.7 | - | - | $ 40.3 B | ||
|
Albireo Pharma
ALBO
|
-3.38 | - | -0.23 % | $ 916 M | ||
|
Ayala Pharmaceuticals
AYLA
|
0.785 | - | - | $ 7.46 M | ||
|
Aptorum Group Limited
APM
|
29.4 | $ 1.33 | -1.48 % | $ 7.25 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-0.994 | $ 3.4 | 1.49 % | $ 8.18 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.42 | - | -1.52 % | $ 24.7 M | ||
|
AstraZeneca PLC
AZN
|
76.5 | $ 90.34 | -1.28 % | $ 96.9 B | ||
|
Amphastar Pharmaceuticals
AMPH
|
17.3 | $ 25.76 | 0.19 % | $ 1.25 B | ||
|
Anika Therapeutics
ANIK
|
38.7 | $ 9.53 | -1.19 % | $ 140 M | ||
|
Brickell Biotech
BBI
|
0.668 | - | -5.38 % | $ 6.06 M | ||
|
BeiGene, Ltd.
BGNE
|
-208 | - | 0.49 % | $ 251 B | ||
|
Biogen
BIIB
|
12.7 | $ 173.03 | -2.55 % | $ 25.2 B | ||
|
BioVie
BIVI
|
-0.244 | $ 1.54 | -2.53 % | $ 2.28 M | ||
|
Bellicum Pharmaceuticals
BLCM
|
1.13 | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
-16.9 | - | -7.31 % | $ 87 M | ||
|
Aytu BioScience
AYTU
|
-1.92 | $ 2.33 | 2.3 % | $ 14.6 M | ||
|
Arena Pharmaceuticals
ARNA
|
-9.01 | - | -6.81 % | $ 3.04 B | ||
|
Baudax Bio
BXRX
|
-1.99 | - | 0.59 % | $ 63 K | ||
|
Avenue Therapeutics
ATXI
|
0.871 | - | -52.27 % | $ 4.45 M | ||
|
Catalyst Biosciences
CBIO
|
0.34 | $ 15.32 | 5.73 % | $ 1.01 B | ||
|
Институт стволовых клеток человека
ISKJ
|
14 | - | - | - | ||
|
ChromaDex Corporation
CDXC
|
-5.05 | - | -0.88 % | $ 598 M | ||
|
Axon Enterprise
AXON
|
-63.9 | $ 586.28 | 3.15 % | $ 44.4 B | ||
|
Cerus Corporation
CERS
|
-24.7 | $ 2.14 | 13.23 % | $ 395 M | ||
|
Checkpoint Therapeutics
CKPT
|
-0.833 | - | - | $ 169 M | ||
|
Caladrius Biosciences
CLBS
|
0.677 | - | -16.75 % | $ 25.8 M | ||
|
Celldex Therapeutics
CLDX
|
0.185 | $ 28.33 | 0.5 % | $ 1.82 M | ||
|
Cellectar Biosciences
CLRB
|
1.31 | $ 3.81 | -5.35 % | $ 46.6 M | ||
|
Clovis Oncology
CLVS
|
-3.86 | - | -7.23 % | $ 13 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-43.1 | $ 0.29 | -5.01 % | $ 631 M | ||
|
Cortexyme
CRTX
|
-1.37 | - | -1.05 % | $ 67.1 M | ||
|
Benitec Biopharma
BNTC
|
0.734 | $ 12.91 | 0.78 % | $ 531 M | ||
|
Cytokinetics, Incorporated
CYTK
|
-2.65 | $ 60.38 | 0.11 % | $ 6.76 M | ||
|
BioNTech SE
BNTX
|
4.1 | $ 95.9 | 0.17 % | $ 27.2 B | ||
|
Deciphera Pharmaceuticals
DCPH
|
-1.5 | - | - | $ 2.18 B | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
-14.9 | $ 11.55 | 8.86 % | $ 747 M | ||
|
Dynavax Technologies Corporation
DVAX
|
12.8 | $ 10.89 | -0.09 % | $ 1.42 B | ||
|
Eloxx Pharmaceuticals
ELOX
|
0.296 | - | -5.68 % | $ 8.28 M | ||
|
Acer Therapeutics
ACER
|
-3.39 | - | 2.71 % | $ 14 M |